Write a short note on Papillary Carcinoma of the Thyroid.

The Concept

Papillary carcinoma is the commonest thyroid cancer (about 70%) and arises from the follicular cells. Its defining feature is a paradox that makes it a favourite exam topic: despite frequently spreading to lymph nodes, it has an excellent prognosis. It is commonest in young women and is the type classically linked to previous ionising radiation to the neck (e.g. In childhood).

Pathology & Spread

Histologically it shows characteristic 'Orphan Annie eye' nuclei (clear, empty-looking), nuclear grooves, and psammoma bodies (laminated calcifications). It is often multifocal within the gland. Crucially, its main route of spread is lymphatic — to the cervical lymph nodes — rather than by the bloodstream; nodal involvement is common yet, unlike most cancers, does not greatly worsen the good prognosis in younger patients.

Clinical Features & Investigation

It usually presents as a painless thyroid nodule, sometimes with a palpable cervical lymph node (occasionally the node is the presenting complaint). Diagnosis is by ultrasound and FNAC (papillary cytology is reliably diagnostic on aspiration, unlike follicular lesions).

Management

Treatment is total thyroidectomy (or hemithyroidectomy for a small, low-risk, unifocal tumour), with neck dissection for involved nodes. This is followed by radioiodine ablation of any residual or metastatic thyroid tissue, and lifelong thyroxine to suppress TSH (which would otherwise stimulate any remaining tumour). Serum thyroglobulin is then used as a sensitive marker to detect recurrence during follow-up.

Variants & Long-term Outlook

Several histological variants exist (follicular, tall-cell and others), and the tiny papillary microcarcinoma (< 1 cm), increasingly found incidentally, may be managed conservatively. Overall the outlook is among the best of any cancer — 10-year survival exceeds 90% in younger patients — provided treatment and TSH-suppressed follow-up are adhered to. The main determinants of a worse outcome are older age, large size and extrathyroidal extension rather than nodal spread.

Management Nuances

Management is stratified by risk. A small, unifocal, low-risk papillary microcarcinoma may be treated with hemithyroidectomy alone (or, in selected cases, active surveillance), whereas larger, multifocal or node-positive tumours warrant total thyroidectomy with radioiodine ablation and TSH suppression. Involved neck nodes are treated by compartment-oriented neck dissection. Long-term follow-up rests on serum thyroglobulin and neck ultrasound, exploiting the fact that, after all thyroid tissue is removed, any measurable thyroglobulin indicates residual or recurrent tumour.

The Bottom Line

Because papillary carcinoma is so often curable, the emphasis of care is on appropriate — not excessive — treatment and on lifelong surveillance. The excellent prognosis (10-year survival >90% in younger patients) depends on complete surgery, selective radioiodine, TSH suppression and diligent follow-up with thyroglobulin and ultrasound, so that the small number of recurrences are detected and re-treated early while they remain curable.

Node involvement does not carry the poor prognosis it does elsewhere.

• Commonest thyroid cancer (~70%); follicular-cell origin; young women; radiation-linked.
• Histology: 'Orphan Annie' nuclei, nuclear grooves, psammoma bodies; often multifocal.
• Spreads by lymphatics to cervical nodes; excellent prognosis despite nodal spread.
• Diagnosed by ultrasound + FNAC (reliably diagnostic).
• Total thyroidectomy (± neck dissection) + radioiodine ablation + TSH-suppressive thyroxine; thyroglobulin as follow-up marker.